Pivotal study of Diazoxide Choline Controlled-Release Tablet (DCCR) for the treatment of Prader-Willi Syndrome

Trial Profile

Pivotal study of Diazoxide Choline Controlled-Release Tablet (DCCR) for the treatment of Prader-Willi Syndrome

Planning
Phase of Trial: Phase II/III

Latest Information Update: 11 May 2017

At a glance

  • Drugs Diazoxide
  • Indications Prader-Willi syndrome
  • Focus Registrational; Therapeutic Use
  • Sponsors Essentialis
  • Most Recent Events

    • 15 Mar 2017 According to Capnia media release, company is planning to initiate this trial later this year.
    • 27 Dec 2016 According to Capnia media release, enrollment is expected to begin in second half of 2017.
    • 01 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top